The disconnect between this promising science and clinical application is stark: not a single human trial exists for mental health applications, leaving patients and clinicians with compelling mechanisms but zero human efficacy or safety data
Recalls & Warnings April 03, 2024 FDA Warns Ambaya Gold for Promoting Products for Depression, Cancer, & Arthritis On December 5, 2023, the FDA issued a Warning Letter to Ambaya Gold Health Products, LLC following review of the companys website and social media, which found statements about the companys Brain Balance, Immune System Boost, Dentist In A Bottle, Essensiac, Fulvic Green, Silver
Unwin, R.D., Smith, D.L., Blinco, D., Wilson, C.L., Miller, C.J., Evans, C.A., Jaworska, E., Baldwin, S.A., Barnes, K., Pierce, A., Spooncer, E
CagriSema is investigational and isnt yet approved here